Select Page ::

Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center

Posted on April 27, 2022 by Fredricko

Visit link:
Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center

Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

Posted on April 27, 2022 by Fredricko

Continued here:
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

Saniona Changes Date of Annual Report for 2021

Posted on April 27, 2022 by Fredricko

Excerpt from:
Saniona Changes Date of Annual Report for 2021

Vistin Pharma ASA: First quarter 2022 financial results

Posted on April 27, 2022 by Fredricko

Continue reading here:
Vistin Pharma ASA: First quarter 2022 financial results

Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase

Posted on December 31, 2021 by Fredricko

Read more from the original source:
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase

AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia

Posted on April 27, 2022 by Fredricko

View post:
AviadoBio’s Gene Therapy Candidate Receives Orphan Designation from Food and Drug Administration and European Commission in Frontotemporal Dementia

Total number of shares and voting rights in Zealand Pharma at December 30, 2021

Posted on December 31, 2021 by Fredricko

See the original post:
Total number of shares and voting rights in Zealand Pharma at December 30, 2021

Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2…

Posted on December 31, 2021 by Fredricko

Follow this link:
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2...

Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022

Posted on December 31, 2021 by Fredricko

More here:
Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022

Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs

Posted on December 21, 2021 by Fredricko

Read the rest here:
Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs

Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes

Posted on December 31, 2021 by Fredricko

Read more from the original source:
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes

Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba® (isavuconazole) in China

Posted on December 21, 2021 by Fredricko

Read the original post:
Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba® (isavuconazole) in China

Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID

Posted on December 21, 2021 by Fredricko

See the rest here:
Statera Biopharma Announces First Patient Dosed in Study of STAT-205 for Acute COVID

TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy

Posted on October 5, 2021 by Fredricko

More here:
TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy

Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities

Posted on October 5, 2021 by Fredricko

See original here:
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities

Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021

Posted on November 7, 2021 by Fredricko

See more here:
Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021

Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted…

Posted on October 5, 2021 by Fredricko

Read the original:
Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted...

Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference

Posted on October 5, 2021 by Fredricko

See the rest here:
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference

Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19…

Posted on February 15, 2021 by Fredricko

Read the original here:
Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19...

Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of…

Posted on May 26, 2021 by Fredricko

Continued here:
Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of...

Select Page ::